Gastroenteritis Global Clinical Trials Review, H1, 2016


Posted December 8, 2016 by Shirley

“Gastroenteritis Global Clinical Trials Review, H1, 2016″ provides an overview of Gastroenteritis clinical trials scenario.
 
MRRS adds "Gastroenteritis Global Clinical Trials Review, H1, 2016" latest studies, published in Nov 2016.

Summary
GlobalData’s clinical trial report, “Gastroenteritis Global Clinical Trials Review, H1, 2016″ provides an overview of Gastroenteritis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroenteritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

Table of Contents
Table of Contents 2
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Gastroenteritis to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Gastroenteritis to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Gastroenteritis Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Gastroenteritis 32
Mar 01, 2016: RedHill Biopharma Provides Update on RHB-102 32
Clinical Trial Profile Snapshots 33
Appendix 121
Abbreviations 121
Definitions 121...

List of Tables and Figures
Gastroenteritis Therapeutics, Global, Clinical Trials by Region, 2016* 6
Gastroenteritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Gastroenteritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Gastroenteritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
Gastroenteritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
Gastroenteritis Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
Gastroenteritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13
Gastroenteritis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016
Proportion of Gastroenteritis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 15
Gastroenteritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
Gastroenteritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
Proportion of Gastroenteritis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 18
Gastroenteritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Gastroenteritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
Gastroenteritis Therapeutics, Global, Clinical Trials by Phase, 2016* 21
Gastroenteritis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22
Gastroenteritis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23...

Browse Complete Report with TOC @
http://www.marketresearchreportstore.com/shop/gastroenteritis-global-clinical-trials-review-h1-2016

Ask a sample or any futher questions, please feel free to contact us:
Tel: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market Research Report Store
Country United States
Categories Business , Reports , Research
Last Updated December 8, 2016